Firmicutes/Bacterioidetes Ratio as an Indicator of Intestinal Microflora
Keywords:
Intestine, microflora, Firmicutes, Bacterioidetes, biological properties, LPSAbstract
Today, advances in fundamental and clinical microbiology show that the correct formation of intestinal microflora from the earliest days of human development serves as the basis for subsequent stages of development. This article presents information about representatives of two main groups of intestinal microflora, their relationship, factors influencing them, as well as changes in the biological characteristics of representatives of this group in various pathological conditions of the body. A prospective target for the treatment or avoidance of inflammatory and metabolic diseases in humans is the gut flora. The identification of particular microbial signatures, particularly those linked to obesity, type 2 diabetes, and cardiovascular illnesses, is the focus of a large portion of current research efforts. According to certain research, the gut microbiota of obese humans and animals has a greater Firmicutes/Bacteroidetes ratio than that of people of normal weight, suggesting that this ratio may one day be used as a biomarker. As a result, a common indicator of obesity in the scientific literature is the Firmicutes/Bacteroidetes ratio. Given the large number of conflicting findings documented in the literature, the purpose of this review was to examine the validity of this putative marker. These disparities could be explained by the presence of interpretative bias brought about by methodological variations in DNA sequence analysis and sample processing, or by the generally subpar characterization of the subjects recruited and, more specifically, the failure to take lifestyle-related factors that are known to influence microbiota diversity and/or composition into account. Because of these factors, it is currently challenging to regard the Firmicutes/Bacteroidetes ratio as a sign of obesity and to link it to a specific health condition.
References
1. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473:174-80.
2. D`Argenio V, Salvatore F. The role of the gut microbiome in the healthy adult status/ Clin Chim Acta. 2015;451(PtA):97-102.
3. Fukiya S, Arata M, Kawashima H, Yoshida D, Kaneko M, Minamida K, Watanabe J, Ogura Y, Uchida K, Itoh K, et al. Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteriodes intestinalis AM-1 isolated from human feces. FEMS Microbiol. Lett.2009, 293, 263-270.
4. Liu Z, Lin S, Liu H, et al. The intestinal microbiota associated with cardiac valve calcification differs from that coronary artery disease. Atherosclerosis. 2019;284:121-8.
5. Miele L, Giorgio V, Alberelli MA, et al. Impact of gut microbiota on obesity, diabetes and cardiovascular disease risk. Curr Cardiol Rep. 2015;17:120.
6. Qin J, Li R, Raes J, Arumugam M, Burgdorf K, Manichanh C, Nielson T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59-65.
7. Roys S, Trinchieri G. Microbiota: A key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17:271-85.
8. Yekani M, Baghi HB, Naqhili B, Vahed SZ, Soki J, Memar MY. To resist and persist: Important factors in the pathogenesis of Bacteroides fragilis. Microb Pathog. 2020. December .Volume 149.
9. Yoshida N, Yamashita T, Kishino S, et al. A possible beneficial effect of Bacteroides on faecal activity and cardiovascular diseases. Scientific repots. 2020, 10:13009.
10. Yoshida N, Emoto T, Yamashita T, et al. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis. Circulation. 2018;138(22):2486-2498.
11. Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, Balamurugan R. The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients? Nutrients. 2020 May 19;12(5):1474. doi: 10.3390/nu12051474.
12. Wei, S.; Bahl, M.I.; Baunwall, S.M.D.; Hvas, C.L.; Licht, T.R. Determining Gut Microbial Dysbiosis: A Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances. Appl. Environ. Microbiol. 2021, 87, e00395-21.
13. Cuevas-Sierra, A.; Ramos-Lopez, O.; Riezu-Boj, J.I.; Milagro, F.I.; Martinez, J.A. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications. Adv. Nutr. 2019, 10 (Suppl. S1), S17–S30.
14. Salazar, J.; Angarita, L.; Morillo, V.; Navarro, C.; Martínez, M.S.; Chacín, M.; Torres, W.; Rajotia, A.; Rojas, M.; Cano, C.; et al. Microbiota and Diabetes Mellitus: Role of Lipid Mediators. Nutrients 2020, 12, 3039
15. Sánchez-Alcoholado, L.; Fernández-García, J.C.; Gutiérrez-Repiso, C.; Bernal-López, M.R.; Ocaña-Wilhelmi, L.; García-Fuentes, E.; Moreno-Indias, I.; Tinahones, F.J. Incidental Prophylactic Appendectomy Is Associated with a Profound Microbial Dysbiosis in the Long-Term. Microorganisms 2020, 8, 609.
16. Gerić, M.; Matković, K.; Gajski, G.; Rumbak, I.; Štancl, P.; Karlić, R.; Bituh, M. Adherence to Mediterranean Diet in Croatia: Lessons Learned Today for a Brighter Tomorrow. Nutrients 2022, 14, 3725.
17. Ahn, J.; Hayes, R.B. Environmental Influences on the Human Microbiome and Implications for Noncommunicable Disease. Annu. Rev. Public Health 2021, 42, 277–292.
18. Pinart, M.; Dötsch, A.; Schlicht, K.; Laudes, M.; Bouwman, J.; Forslund, S.K.; Pischon, T.; Nimptsch, K. Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis. Nutrients 2021, 14, 12.
19. Hajjo, R.; Sabbah, D.A.; Al Bawab, A.Q. Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers. Diagnostics 2022, 12, 1742.
20. Puschhof, J.; Elinav, E. Human microbiome research: Growing pains and future promises. PLoS Biol. 2023, 21, e3002053.
21. Rinninella, E.; Raoul, P.; Cintoni, M.; Franceschi, F.; Miggiano, G.A.D.; Gasbarrini, A.; Mele, M.C. What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms 2019, 7, 14.
